Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 197

1.

Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial.

Dovc K, Piona C, Yeşiltepe Mutlu G, Bratina N, Jenko Bizjan B, Lepej D, Nimri R, Atlas E, Muller I, Kordonouri O, Biester T, Danne T, Phillip M, Battelino T.

Diabetes Care. 2019 Oct 1. pii: dc190895. doi: 10.2337/dc19-0895. [Epub ahead of print]

PMID:
31575640
2.

Impact of attention deficit hyperactivity disorder on metabolic control in adolescents with type1 diabetes.

Macek J, Battelino T, Bizjak M, Zupanc C, Bograf AK, Vesnic S, Klemencic S, Volk E, Bratina N.

J Psychosom Res. 2019 Aug 25;126:109816. doi: 10.1016/j.jpsychores.2019.109816. [Epub ahead of print]

PMID:
31493719
3.

Development of a pilot rare disease registry: a focus group study of initial steps towards the establishment of a rare disease ecosystem in Slovenia.

Stanimirovic D, Murko E, Battelino T, Groselj U.

Orphanet J Rare Dis. 2019 Jul 9;14(1):172. doi: 10.1186/s13023-019-1146-x.

4.

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M.

Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8. Review.

5.

Comparison of liquid chromatography with tandem mass spectrometry and ion-exchange chromatography by post-column ninhydrin derivatization for amino acid monitoring.

Smon A, Cuk V, Brecelj J, Murko S, Groselj U, Zerjav Tansek M, Battelino T, Repic Lampret B.

Clin Chim Acta. 2019 Aug;495:446-450. doi: 10.1016/j.cca.2019.05.007. Epub 2019 May 8.

PMID:
31077651
6.

Dual Role of PTPN22 but Not NLRP3 Inflammasome Polymorphisms in Type 1 Diabetes and Celiac Disease in Children.

Smigoc Schweiger D, Goricar K, Hovnik T, Mendez A, Bratina N, Brecelj J, Vidan-Jeras B, Battelino T, Dolzan V.

Front Pediatr. 2019 Mar 12;7:63. doi: 10.3389/fped.2019.00063. eCollection 2019.

7.

Technologies in Diabetes-the Tenth ATTD Yearbook.

Battelino T, Phillip M.

Diabetes Technol Ther. 2019 Feb;21(S1):S3. doi: 10.1089/dia.2019.2500. No abstract available.

PMID:
30785330
8.

Continuous Glucose Monitoring in 2018.

Bode BW, Battelino T.

Diabetes Technol Ther. 2019 Feb;21(S1):S13-S31. doi: 10.1089/dia.2019.2502. Review. No abstract available.

PMID:
30785326
9.

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.

Danne T, Garg S, Peters AL, Buse JB, Mathieu C, Pettus JH, Alexander CM, Battelino T, Ampudia-Blasco FJ, Bode BW, Cariou B, Close KL, Dandona P, Dutta S, Ferrannini E, Fourlanos S, Grunberger G, Heller SR, Henry RR, Kurian MJ, Kushner JA, Oron T, Parkin CG, Pieber TR, Rodbard HW, Schatz D, Skyler JS, Tamborlane WV, Yokote K, Phillip M.

Diabetes Care. 2019 Jun;42(6):1147-1154. doi: 10.2337/dc18-2316. Epub 2019 Feb 6. Review.

PMID:
30728224
10.

A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5).

Klonoff DC, Evans ML, Lane W, Kempe HP, Renard E, DeVries JH, Graungaard T, Hyseni A, Gondolf T, Battelino T.

Diabetes Obes Metab. 2018 Dec 9. doi: 10.1111/dom.13610. [Epub ahead of print]

11.

DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.

Biester T, Nir J, Remus K, Farfel A, Muller I, Biester S, Atlas E, Dovc K, Bratina N, Kordonouri O, Battelino T, Philip M, Danne T, Nimri R.

Diabetes Obes Metab. 2018 Nov 26. doi: 10.1111/dom.13585. [Epub ahead of print]

PMID:
30478937
12.

Hyperinsulinism-hyperammonemia Syndrome in an Infant with Seizures.

Strajnar A, Tansek MZ, Podkrajsek KT, Battelino T, Groselj U.

Balkan J Med Genet. 2018 Oct 29;21(1):77-81. doi: 10.2478/bjmg-2018-0014. eCollection 2018 Jun.

13.

Continuous glucose monitoring use and glucose variability in pre-school children with type 1 diabetes.

Dovc K, Cargnelutti K, Sturm A, Selb J, Bratina N, Battelino T.

Diabetes Res Clin Pract. 2019 Jan;147:76-80. doi: 10.1016/j.diabres.2018.10.005. Epub 2018 Oct 15.

14.

Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.

Groselj U, Kovac J, Sustar U, Mlinaric M, Fras Z, Podkrajsek KT, Battelino T.

Atherosclerosis. 2018 Oct;277:383-391. doi: 10.1016/j.atherosclerosis.2018.06.858.

PMID:
30270075
15.

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies.

Sherr JL, Tauschmann M, Battelino T, de Bock M, Forlenza G, Roman R, Hood KK, Maahs DM.

Pediatr Diabetes. 2018 Oct;19 Suppl 27:302-325. doi: 10.1111/pedi.12731. No abstract available.

PMID:
30039513
16.

Non-adjunctive flash glucose monitoring system use during summer-camp in children with type 1 diabetes: The free-summer study.

Piona C, Dovc K, Mutlu GY, Grad K, Gregorc P, Battelino T, Bratina N.

Pediatr Diabetes. 2018 Nov;19(7):1285-1293. doi: 10.1111/pedi.12729. Epub 2018 Aug 16.

PMID:
30022571
17.

Efficacy and safety of a fixed combination of insulin degludec/insulin aspart in children and adolescents with type 1 diabetes: A randomized trial.

Battelino T, Deeb LC, Ekelund M, Kinduryte O, Klingensmith GJ, Kocova M, Kovarenko M, Shehadeh N.

Pediatr Diabetes. 2018 Nov;19(7):1263-1270. doi: 10.1111/pedi.12724. Epub 2018 Aug 16.

PMID:
30014589
18.

ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes.

Danne T, Phillip M, Buckingham BA, Jarosz-Chobot P, Saboo B, Urakami T, Battelino T, Hanas R, Codner E.

Pediatr Diabetes. 2018 Oct;19 Suppl 27:115-135. doi: 10.1111/pedi.12718. No abstract available.

PMID:
29999222
19.

Association of Glycemic Control and Cell Stress With Telomere Attrition in Type 1 Diabetes.

Tesovnik T, Kovac J, Hovnik T, Dovc K, Bratina N, Battelino T, Trebušak Podkrajšek K.

JAMA Pediatr. 2018 Sep 1;172(9):879-881. doi: 10.1001/jamapediatrics.2018.1175. No abstract available.

20.

Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians.

Nimri R, Dassau E, Segall T, Muller I, Bratina N, Kordonouri O, Bello R, Biester T, Dovc K, Tenenbaum A, Brener A, Šimunović M, Sakka SD, Nevo Shenker M, Passone CG, Rutigliano I, Tinti D, Bonura C, Caiulo S, Ruszala A, Piccini B, Giri D, Stein R, Rabbone I, Bruzzi P, Omladič JŠ, Steele C, Beccuti G, Yackobovitch-Gavan M, Battelino T, Danne T, Atlas E, Phillip M.

Diabetes Obes Metab. 2018 Oct;20(10):2458-2466. doi: 10.1111/dom.13408. Epub 2018 Jul 18.

PMID:
29885025
21.

Metabolic control, ApoE genotypes, and dyslipidemia in children, adolescents and young adults with type 1 diabetes.

Macedoni M, Hovnik T, Plesnik E, Kotnik P, Bratina N, Battelino T, Groselj U.

Atherosclerosis. 2018 Jun;273:53-58. doi: 10.1016/j.atherosclerosis.2018.04.013. Epub 2018 Apr 12.

PMID:
29679801
22.

Continuous Glucose Monitoring Efficacy in Routine Use.

Battelino T.

J Clin Endocrinol Metab. 2018 Jun 1;103(6):2414-2416. doi: 10.1210/jc.2018-00275. No abstract available.

23.

Continuous Glucose Monitoring in 2017.

Battelino T, Bode BW.

Diabetes Technol Ther. 2018 Feb;20(S1):S13-S29. doi: 10.1089/dia.2018.2502. Review. No abstract available.

PMID:
29437476
24.

Technologies in Diabetes-the Ninth ATTD Yearbook.

Battelino T, Phillip M.

Diabetes Technol Ther. 2018 Feb;20(S1):S2. doi: 10.1089/dia.2018.2500. No abstract available.

PMID:
29437473
25.

Medium-chain acyl-CoA dehydrogenase deficiency: Two novel ACADM mutations identified in a retrospective screening.

Smon A, Groselj U, Debeljak M, Zerjav Tansek M, Bertok S, Avbelj Stefanija M, Trebusak Podkrajsek K, Battelino T, Repic Lampret B.

J Int Med Res. 2018 Apr;46(4):1339-1348. doi: 10.1177/0300060517734123. Epub 2018 Jan 19.

26.

Circulating levels of miR-122 and nonalcoholic fatty liver disease in pre-pubertal obese children.

Brandt S, Roos J, Inzaghi E, Kotnik P, Kovac J, Battelino T, Cianfarani S, Nobili V, Colajacomo M, Kratzer W, Denzer C, Fischer-Posovszky P, Wabitsch M.

Pediatr Obes. 2018 Mar;13(3):175-182. doi: 10.1111/ijpo.12261. Epub 2017 Dec 22.

PMID:
29271122
27.

Identification of novel alleles associated with insulin resistance in childhood obesity using pooled-DNA genome-wide association study approach.

Kotnik P, Knapič E, Kokošar J, Kovač J, Jerala R, Battelino T, Horvat S.

Int J Obes (Lond). 2018 Apr;42(4):686-695. doi: 10.1038/ijo.2017.293. Epub 2017 Nov 30.

28.

International Consensus on Use of Continuous Glucose Monitoring.

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M.

Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600. Review.

29.

Next generation sequencing as a follow-up test in an expanded newborn screening programme.

Smon A, Repic Lampret B, Groselj U, Zerjav Tansek M, Kovac J, Perko D, Bertok S, Battelino T, Trebusak Podkrajsek K.

Clin Biochem. 2018 Feb;52:48-55. doi: 10.1016/j.clinbiochem.2017.10.016. Epub 2017 Oct 27.

PMID:
29111448
30.

Autoantibody Repertoire in APECED Patients Targets Two Distinct Subgroups of Proteins.

Fishman D, Kisand K, Hertel C, Rothe M, Remm A, Pihlap M, Adler P, Vilo J, Peet A, Meloni A, Podkrajsek KT, Battelino T, Bruserud Ø, Wolff ASB, Husebye ES, Kluger N, Krohn K, Ranki A, Peterson H, Hayday A, Peterson P.

Front Immunol. 2017 Aug 16;8:976. doi: 10.3389/fimmu.2017.00976. eCollection 2017.

31.

Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial.

Dovc K, Macedoni M, Bratina N, Lepej D, Nimri R, Atlas E, Muller I, Kordonouri O, Biester T, Danne T, Phillip M, Battelino T.

Diabetologia. 2017 Nov;60(11):2157-2167. doi: 10.1007/s00125-017-4395-z. Epub 2017 Aug 24.

32.

The association of SCN1A p.Thr1067Ala polymorphism with epilepsy risk and the response to antiepileptic drugs in Slovenian children and adolescents with epilepsy.

Bertok S, Dolžan V, Goričar K, Podkrajšek KT, Battelino T, Rener-Primec Z.

Seizure. 2017 Oct;51:9-13. doi: 10.1016/j.seizure.2017.07.007. Epub 2017 Jul 20.

33.

Multifocal gastric adenocarcinoma in a patient with LRBA deficiency.

Bratanič N, Kovač J, Pohar K, Trebušak Podkrajšek K, Ihan A, Battelino T, Avbelj Stefanija M.

Orphanet J Rare Dis. 2017 Jul 18;12(1):131. doi: 10.1186/s13023-017-0682-5.

34.

Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial.

Battelino T, Rasmussen MH, De Schepper J, Zuckerman-Levin N, Gucev Z, Sävendahl L; NN8640-4042 Study Group.

Clin Endocrinol (Oxf). 2017 Oct;87(4):350-358. doi: 10.1111/cen.13409. Epub 2017 Aug 8.

PMID:
28656605
35.

Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial.

Battelino T, Nimri R, Dovc K, Phillip M, Bratina N.

Diabetes Care. 2017 Jun;40(6):764-770. doi: 10.2337/dc16-2584. Epub 2017 Mar 28.

PMID:
28351897
36.

Characterization of a de novo sSMC 17 detected in a girl with developmental delay and dysmorphic features.

Stavber L, Bertok S, Kovač J, Volk M, Lovrečić L, Battelino T, Hovnik T.

Mol Cytogenet. 2017 Mar 23;10:10. doi: 10.1186/s13039-017-0312-x. eCollection 2017.

37.

Technologies in Diabetes-The Eighth ATTD Yearbook.

Battelino T, Phillip M.

Diabetes Technol Ther. 2017 Feb;19(S1):S2. doi: 10.1089/dia.2017.2500. No abstract available.

PMID:
28192025
38.

Continuous Glucose Monitoring in 2016.

Bode BW, Battelino T.

Diabetes Technol Ther. 2017 Feb;19(S1):S11-S18. doi: 10.1089/dia.2017.2502. Review. No abstract available.

PMID:
28192020
39.

Obesity, Metabolic Syndrome, and Nutrition.

Shalitin S, Battelino T, Moreno LA.

World Rev Nutr Diet. 2017;116:16-51. doi: 10.1159/000452185. Epub 2017 Feb 6. No abstract available.

PMID:
28166527
40.

Striving for control: lessons learned from a successful international Type 1 Diabetes Youth Challenge.

Kordonouri O, Vazeou A, Scharf M, Würsig M, Battelino T; SWEET Group.

Acta Diabetol. 2017 Apr;54(4):403-409. doi: 10.1007/s00592-017-0964-3. Epub 2017 Feb 2.

PMID:
28154987
41.

MD-Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trial.

Nimri R, Bratina N, Kordonouri O, Avbelj Stefanija M, Fath M, Biester T, Muller I, Atlas E, Miller S, Fogel A, Phillip M, Danne T, Battelino T.

Diabetes Obes Metab. 2017 Apr;19(4):553-561. doi: 10.1111/dom.12852. Epub 2017 Jan 19.

PMID:
27981804
42.

IL-6-specific autoantibodies among APECED and thymoma patients.

Kärner J, Pihlap M, Ranki A, Krohn K, Trebusak Podkrajsek K, Bratanic N, Battelino T, Willcox N, Peterson P, Kisand K.

Immun Inflamm Dis. 2016 May 25;4(2):235-243. eCollection 2016 Jun.

43.

Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline.

Peters AL, Ahmann AJ, Battelino T, Evert A, Hirsch IB, Murad MH, Winter WE, Wolpert H.

J Clin Endocrinol Metab. 2016 Nov;101(11):3922-3937. Epub 2016 Sep 2.

PMID:
27588440
44.

Stabilization of Overweight and Obesity in Slovenian Adolescents and Increased Risk in Those Entering Non-Grammar Secondary Schools.

Sedej K, Lusa L, Battelino T, Kotnik P.

Obes Facts. 2016;9(4):241-50. doi: 10.1159/000445382. Epub 2016 Jul 26.

45.

Fear of hypoglycemia, anxiety, and subjective well-being in parents of children and adolescents with type 1 diabetes.

Pate T, Klemenčič S, Battelino T, Bratina N.

J Health Psychol. 2019 Feb;24(2):209-218. doi: 10.1177/1359105316650931. Epub 2016 Jun 7.

PMID:
27278280
46.

Functional Significance and Predictive Value of MicroRNAs in Pediatric Obesity: Tiny Molecules with Huge Impact?

Fischer-Posovszky P, Roos J, Kotnik P, Battelino T, Inzaghi E, Nobili V, Cianfarani S, Wabitsch M.

Horm Res Paediatr. 2016;86(1):3-10. doi: 10.1159/000444677. Epub 2016 May 10. Review.

47.

High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease.

Smigoc Schweiger D, Mendez A, Kunilo Jamnik S, Bratanic N, Bratina N, Battelino T, Brecelj J, Vidan-Jeras B.

Autoimmunity. 2016 Jun;49(4):240-7. doi: 10.3109/08916934.2016.1164144. Epub 2016 Apr 20.

PMID:
27138053
48.

Clinical Role of CYP2C19 Polymorphisms in Patients with Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency.

Grošelj U, Žerjav Tanšek M, Trebušak Podkrajšek K, Hovnik T, Battelino T, Vita D.

Acta Chim Slov. 2016;63(1):33-7.

PMID:
26970786
49.

Long-term BH4 (sapropterin) treatment of children with hyperphenylalaninemia - effect on median Phe/Tyr ratios.

Tansek MZ, Groselj U, Kelvisar M, Kobe H, Lampret BR, Battelino T.

J Pediatr Endocrinol Metab. 2016 May 1;29(5):561-6. doi: 10.1515/jpem-2015-0337.

PMID:
26910740
50.

Obesity, Metabolic Syndrome and Nutrition.

Shalitin S, Battelino T, Moreno LA.

World Rev Nutr Diet. 2016;114:21-49. doi: 10.1159/000441810. Epub 2016 Feb 23. Review. No abstract available.

PMID:
26906026

Supplemental Content

Loading ...
Support Center